Numinus Wellness Announces Q3 Results
Mental healthcare company advancing psychedelic-assisted therapies Numinus Wellness Inc. (OTCQX: NUMIF) recently announced its fiscal quarter results for the three and nine months ended May 31, 2022.
Marijuana Stock Movers For July 15, 2022
GAINERS:
MGC Pharmaceuticals (OTC:MGCLF) shares closed up 37.98% at $0.02
Allied, Compass Pathways Among Top Psychedelic Movers Of Today
GAINERS:
Allied (OTC:ALID) shares closed up 7.05% at $0.52
Cannabis Stock Short Sellers Have $807M In Profits So Far In 2022
After a horrible 2021 for cannabis investors, the AdvisorShares Pure US Cannabis ETF (NYSE: MSOS) is down another 55.1% in 2022.
President Joe Biden and a Democrat-controlled Congress have made little progress on U.S. federal cannabis reform.
Sweet Home Chicago: Come For The Cannabis Conference, Stay For The Blues Brothers, The History And The Music!
It’s been over four decades since the release of the watershed film that spread Chicago’s soul sounds around the world when "The Blues Brothers" tore up the streets, the churches, the parks, the coffee shops, the hotels, the back alleys and most of the Windy City.
Why Innovative Industrial Properties Stock Is Trading Lower Today
Innovative Industrial Properties’ (NYSE: IIPR) stock plunged 13.85% on Friday.
Vibe Growth Opening Its Newest Cannabis Dispensary In Salinas, California
Vibe Growth Corporation (OTCQX: VIBEF) (CSE:VIBE) (FSE:A061) a vertically integrated California cannabis enterprise, is opening its newest dispensary location in Salinas, California. The new Vibe By California branded Salinas dispensary is
Indiva To Settle 172k Debt Via Shares For Debt Agreement
Indiva Limited (OTCQX: NDVAF) (TSXV:NDVA) has entered into a shares for debt agreement, to satisfy an aggregate of $172,075.98 of the company's outstanding debt related to accrued but unpaid portions of the interest payments outstanding under certain co
Roth Capital Maintains Neutral on Tilray, Lowers Price Target to $4
Roth Capital analyst Scott Fortune maintains Tilray (NASDAQ:TLRY) with a Neutral and lowers the price target from $8 to $4.
Cantor Fitzgerald Maintains Overweight on OrganiGram Holdings, Lowers Price Target to C$2.9
Cantor Fitzgerald analyst Pablo Zuanic maintains OrganiGram Holdings (TSX:OGI) with a Overweight and lowers the price target from C$3.7 to C$2.9.